Latest Cost Reduction News

AVADA Group Limited reported a seasonally subdued quarter ending March 2025 but achieved positive operating cash flow through disciplined cost reductions and operational efficiencies. A strategic review of its New Zealand operations is underway amid challenging market conditions.

MC Mining reports steady progress on its Makhado hard coking coal project with key construction milestones met, while Uitkomst Colliery faces production setbacks and rising costs amid depressed coal prices.

FBR Limited wraps up its US Demonstration Program, secures $6.3 million in capital, and appoints Mark Pivac as CEO amid a 70% cost reduction drive. Strategic collaborations with Samsung Heavy Industries and Liebherr signal broader automation ambitions.

Atlantic Lithium has secured all essential permits for its flagship Ewoyaa Lithium Project in Ghana and updated its feldspar resource estimate, while navigating funding challenges and awaiting parliamentary ratification of its mining lease.

Evolution Energy Minerals initiates a strategic review and cost-cutting at its Chilalo graphite project while progressing a farm-out deal for its Chikundu Cu-Pb-Zn VHMS prospect with Oscillate plc.

Rare Foods Australia has secured shareholder approval to voluntarily delist from the ASX, while implementing significant cost reductions and achieving record growth in its Subsea Estate wine brand.

Mount Burgess Mining reports encouraging hydrometallurgical test results from its Nxuu polymetallic deposit, achieving high recoveries for zinc, vanadium, and rare earth elements. The company also completed a modest capital raise to support ongoing project development.

Inventis Limited reported solid Q3 cash generation and strong technology sales growth, while actively pursuing international expansion and a $2.5 million USD capital raise for its US Hazavoid entity.

Winchester Energy has signed a non-binding term sheet with Jaguar Exploration to jointly pursue offshore exploration rights in Peru, while maintaining steady production and implementing cost reductions in its Texas operations.

ENRG Elements Limited has completed a strategic overhaul with new management, significant cost reductions, and a renewed focus on its Agadez Uranium Project, while exiting several lithium assets.

Vectus Biosystems advances its lead fibrosis drug VB0004 with validated Phase I safety data and strategic cost reductions, while actively pursuing licensing partnerships in China.

Renascor Resources reports significant engineering advances that increase high-value graphite production by 60%, reduce operating costs, and confirm a safer, eco-friendly purification process.